Skip to Content
Merck
CN
  • Comparative study on biodegradation and biocompatibility of multichannel calcium phosphate based bone substitutes.

Comparative study on biodegradation and biocompatibility of multichannel calcium phosphate based bone substitutes.

Materials science & engineering. C, Materials for biological applications (2020-03-25)
Hoe-Jin Kang, Preeti Makkar, Andrew R Padalhin, Gun-Hee Lee, Soo-Bin Im, Byong-Taek Lee
ABSTRACT

The objective of this study was to fabricate multichannel biphasic calcium phosphate (BCP) and β-tricalcium phosphate (TCP) bone substitutes and compare their long-term biodegradation and bone regeneration potentials. Multi-channel BCP and TCP scaffolds were fabricated by multi-pass extrusion process. Both scaffolds were cylindrical with a diameter of 1-mm, a length of 1-mm, and seven interconnected channels. Morphology, chemical composition, phase, porosity, compressive strength, ion release behavior, and in-vitro biocompatibility of both scaffolds were studied. In-vivo biodegradation and bone regeneration efficacies of BCP and TCP were also evaluated using a rabbit model for 1 week, 1 month, and 6 months. BCP exhibited superior compressive strength compared to TCP scaffold. TCP showed higher release of both calcium ions and phosphorous ions than BCP in SBF solution. Both scaffolds showed excellent in-vitro biocompatibility and upregulated the expression of osteogenic markers of MC3T3-E1 cells. In-vivo studies revealed that both cylindrical TCP and BCP scaffolds were osteoconductive and supported new bone formation. Micro-CT data showed that the bone-regeneration efficacy of TCP was higher at one month and at six months after implantation. Histological examination confirmed that TCP degraded faster and had better bone regeneration than BCP after 6 months.

MATERIALS
Product Number
Brand
Product Description

Supelco
3,5,6-Trichloro-2-pyridinol, PESTANAL®, analytical standard
Sigma-Aldrich
Edelfosine, ≥95% (HPLC)
Sigma-Aldrich
Triton X-100, laboratory grade